Hypertension management: New guidelines expand medication eligibility for millions

New research highlights a significant gap in the management of hypertension in the United States. A study published in the Journal of the American Heart Association indicates that nearly one in three American adults with untreated high blood pressure could benefit from medical intervention but are not receiving it. Under updated guidelines from the American Heart Association and the American College of Cardiology, approximately 81 million Americans may now be eligible for blood pressure medications when considering factors like blood sugar and kidney function.

Lead study author Dr. Mustafa Al-Jarshawi estimated that expanded treatment could prevent approximately 200,900 all-cause deaths and 162,600 cardiovascular deaths over the next decade. Experts note that these new guidelines allow for more aggressive treatment of individuals who were not previously considered high-risk.

Complementary research from institutions including the University of Pennsylvania suggests that patient behavior regarding hypertension management is split. While many patients are motivated to follow medication regimens, they are often less inclined to adopt the lifestyle changes, such as diet and exercise, also recommended by healthcare providers. This suggests that the psychological drivers for taking medication and making lifestyle changes may be distinct.